Fake Drug Crisis Worsens as FDA Faces Severe Staff Shortage

The issue of fake drug supply remains unresolved. Adding to this, it has now come to light that 50% of sanctioned posts are vacant in the Food and Drug Administration (FDA). As a result, controlling the circulation of counterfeit drugs has become increasingly challenging. Now, there are concerns about how the FDA can manage its … Continue reading Fake Drug Crisis Worsens as FDA Faces Severe Staff Shortage